UB-221
UB-221 is a humanized IgG1 monoclonal antibody inhibitor targeting IgE. UB-221 significantly decreases IgE synthesis by stabilization of membrane-bound CD23 on B lymphocytes and inhibits FcԑRI-mediated basophil activation and degranulation. UB-221 reduces IgE level in cynomolgus macaques and human IgE (ε, κ) -transgenic (hIGHE-knockin) mice. UB-221 can be used for asthma and chronic spontaneous urticaria (CSU) research[1].
Product Specifications
CAS Number
[2755114-30-6]
UNSPSC
12352203
Target
Others
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
References & Citations
[1]Kuo BS, et al. IgE-neutralizing UB-221 mAb, distinct from omalizumab and ligelizumab, exhibits CD23-mediated IgE downregulation and relieves urticaria symptoms. J Clin Invest. 2022 Aug 1;132 (15) :e157765. |[2]Casale TB. Novel biologics for treatment of chronic spontaneous urticaria. J Allergy Clin Immunol. 2022 Dec;150 (6) :1256-1259.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
More Discoveries
Explore Other Products
Browse additional items from our catalog
IRTAMSLY6GRB68C5CPERCP200 200 Tests
Anti Mouse Ly-6G/Ly-6C (Gr-1) Flow Cytometry Monoclonal Clone RB68C5 PerCP Ready To Use 200 Tests
Sign In for Pricing
View Details 
K7252407 1.0 µg DNA
Jakmip1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2)
Sign In for Pricing
View Details 
EKU09377 96 Tests
Human Vascular Endothelial Growth Factor 189 (VEGF189) ELISA Kit
Sign In for Pricing
View Details